Nova Eye Medical LtdASX: EYE

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by Nova Eye Medical Ltd via ASX

Filed with ASX ·

ASX RELEASE 27 October 2026 Quarterly Activities and Cashflow Report – September 2026 • Total sales for the quarter ended 30 September 2026 of US$6.3 million, up 30% on PCP • Last twelve months (LTM) sales of US$25.1 million, up 30% on the PCP, an acceleration of the growth rate compared with...

View Attachment

6ix is reading this filing.

Nova Eye Medical Ltd on 6ix

Earlier from Nova Eye Medical

All Nova Eye Medical news releases